Phase II trial of liposomal doxorubicin (Doxil®) in advanced soft tissue sarcomas

T. Chidiac, G. Thomas Budd, R. Pelley, K. Sandstrom, D. McLain, P. Elson, R. Crownover, K. Marks, G. Muschler, M. Joyce, R. Zehr, R. Bukowski

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of liposomal doxorubicin (Doxil®) in advanced soft tissue sarcomas'. Together they form a unique fingerprint.

Medicine & Life Sciences